Printer Friendly

OvaScience's CEO announces stock purchase plan under 10b5-1 purchasing plan.

M2 EQUITYBITES-September 19, 2013-OvaScience's CEO announces stock purchase plan under 10b5-1 purchasing plan(C)2013 M2 COMMUNICATIONS

Life sciences company OvaScience (NasdaqGM:OVAS) declared on Wednesday that its CEO Dr Michelle Dipp has arranged a personal stock purchasing plan to acquire its common stock.

The company added that, under Section 10b5-1 of the Securities Exchange Act of 1934, as amended, the securities holders can adopt pre-arranged stock purchasing plans for the acquisition of predetermined amounts of securities on a non-discretionary basis.

According to the company, the transactions under this 10b5-1 purchasing plan will commence no earlier than 18 November 2013.

((Comments on this story may be sent to>PDSeptember 19, 2013>JNM2 EQUITYBITES.PRICEDATENOT APPLICABLE.DAY

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Sep 19, 2013
Previous Article:ChemoCentryx Inc to regains vercirnon from GlaxoSmithKline.
Next Article:TriMas proposes process plan to refinance debt facilities.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters